Frost Phillip MD Et al - 19 Aug 2025 Form 4 Insider Report for Fluent, Inc. (FLNT)

Reporting relationship: 10%+ Owner
Issuer ticker: FLNT
Reported as of: 19 Aug 2025
Net transaction value: +$1,000,001
SEC form: 4
Accepted by SEC: 21 Aug 2025, 17:02:52 UTC
Prior SEC filing: 19 Aug 2025
Next SEC filing: 12 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Dr. Phillip Frost, M.D., Trustee

Key filing fact

Frost Phillip MD Et al filed Form 4 for Fluent, Inc. (FLNT) on 21 Aug 2025.

Key facts

This page summarizes Frost Phillip MD Et al's Form 4 filing for Fluent, Inc. (FLNT).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 21 Aug 2025, 17:02.

Change

Previous filing in this sequence was filed on 19 Aug 2025.
Current net transaction value: +$1,000,001.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0000898860 Primary reporting owner

FROST PHILLIP MD ET AL

Relationship: 10%+ Owner
Address: 4400 BISCAYNE BLVD, MIAMI
Signature: /s/ Dr. Phillip Frost, M.D., Trustee
Signature date: 21 Aug 2025

CIK 0001380896

Frost Gamma Investments Trust

Relationship: 10%+ Owner
Address: 4400 BISCAYNE BLVD, MIAMI
Signature: /s/ Dr. Phillip Frost, M.D., Individually
Signature date: 21 Aug 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FLNT transaction Derivative

Pre-Funded Warrants

Award

Transaction value: $1,000,001
Shares: +571,429
Change %
Price: $1.75
Shares after: 571,429
Date: 19 Aug 2025
Ownership: Held by Frost Gamma Investments Trust
Underlying class: Common Stock
Underlying amount: 571,429
Exercise price: $0.000500
Footnotes: F1, F2

FLNT transaction Derivative

Warrants

Award

Transaction value: $0
Shares: +571,429
Change %
Price: $0.000000
Shares after: 571,429
Date: 19 Aug 2025
Ownership: Held by Frost Gamma Investments Trust
Underlying class: Common Stock
Underlying amount: 571,429
Exercise price: $2.21
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F2

Each Pre-Funded Warrant is immediately exercisable for one share of the issuer's common stock, $0.0005 par value per share (the "Common Stock"), and will expire when exercised in full.

Footnote F3

Each Warrant will be exercisable for one share of Common Stock at any time on or after the date that is six months and one day following the date of issuance for a period of five and one-half years from the date of issuance. Notwithstanding the foregoing, the Warrants shall be exercisable at any time on or after the date that applicable stockholder approval is obtained and deemed effective and such Warrants shall be exercisable until the expiration date.